Concepts (112)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Patellar Ligament | 2 | 2025 | 12 | 1.870 |
Why?
|
| Tibial Fractures | 2 | 2025 | 60 | 1.770 |
Why?
|
| Fracture Fixation, Internal | 2 | 2025 | 77 | 0.970 |
Why?
|
| Osteoporosis | 1 | 2022 | 116 | 0.720 |
Why?
|
| Bone Density | 1 | 2022 | 318 | 0.660 |
Why?
|
| Psoas Muscles | 1 | 2019 | 5 | 0.630 |
Why?
|
| Pelvic Bones | 1 | 2019 | 26 | 0.620 |
Why?
|
| Sarcopenia | 1 | 2019 | 40 | 0.600 |
Why?
|
| Fractures, Bone | 1 | 2019 | 186 | 0.530 |
Why?
|
| Retrospective Studies | 7 | 2025 | 16273 | 0.280 |
Why?
|
| Monteggia's Fracture | 1 | 2025 | 4 | 0.240 |
Why?
|
| Radiography | 2 | 2024 | 823 | 0.240 |
Why?
|
| Fracture Dislocation | 1 | 2025 | 6 | 0.240 |
Why?
|
| Arthrogryposis | 1 | 2025 | 35 | 0.240 |
Why?
|
| Femur | 1 | 2025 | 67 | 0.240 |
Why?
|
| Hip Dislocation, Congenital | 1 | 2025 | 18 | 0.240 |
Why?
|
| Joint Dislocations | 1 | 2025 | 23 | 0.240 |
Why?
|
| Peripheral Nerve Injuries | 1 | 2025 | 37 | 0.240 |
Why?
|
| Hip Dislocation | 1 | 2025 | 28 | 0.240 |
Why?
|
| Range of Motion, Articular | 1 | 2025 | 67 | 0.230 |
Why?
|
| Rotation | 1 | 2024 | 50 | 0.230 |
Why?
|
| Tendon Injuries | 1 | 2024 | 17 | 0.230 |
Why?
|
| Casts, Surgical | 1 | 2024 | 16 | 0.220 |
Why?
|
| Humeral Fractures | 1 | 2024 | 22 | 0.220 |
Why?
|
| Postoperative Complications | 2 | 2025 | 3062 | 0.200 |
Why?
|
| Absorptiometry, Photon | 1 | 2022 | 177 | 0.190 |
Why?
|
| Benzodioxoles | 2 | 2012 | 9 | 0.190 |
Why?
|
| Reoperation | 1 | 2025 | 830 | 0.190 |
Why?
|
| Colorectal Neoplasms | 3 | 2012 | 564 | 0.190 |
Why?
|
| Lumbar Vertebrae | 1 | 2022 | 113 | 0.190 |
Why?
|
| Patient Education as Topic | 1 | 2024 | 436 | 0.180 |
Why?
|
| Quinazolines | 2 | 2012 | 174 | 0.170 |
Why?
|
| Male | 8 | 2025 | 60994 | 0.170 |
Why?
|
| Child | 6 | 2025 | 24356 | 0.170 |
Why?
|
| Adolescent | 4 | 2025 | 19243 | 0.170 |
Why?
|
| Risk Factors | 3 | 2025 | 10244 | 0.170 |
Why?
|
| Female | 8 | 2025 | 66276 | 0.160 |
Why?
|
| Reproducibility of Results | 2 | 2024 | 2863 | 0.160 |
Why?
|
| Blood-Brain Barrier | 2 | 2009 | 142 | 0.150 |
Why?
|
| Drug Resistance, Neoplasm | 2 | 2012 | 718 | 0.140 |
Why?
|
| Humans | 12 | 2025 | 124149 | 0.130 |
Why?
|
| Follow-Up Studies | 1 | 2025 | 5132 | 0.120 |
Why?
|
| Sex Factors | 1 | 2019 | 1276 | 0.120 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2022 | 2089 | 0.110 |
Why?
|
| Survival Rate | 1 | 2019 | 2035 | 0.110 |
Why?
|
| Age Factors | 1 | 2019 | 2806 | 0.100 |
Why?
|
| Aldehyde Dehydrogenase | 1 | 2012 | 40 | 0.100 |
Why?
|
| Receptor, Notch1 | 1 | 2012 | 64 | 0.100 |
Why?
|
| Camptothecin | 1 | 2012 | 73 | 0.100 |
Why?
|
| 3' Untranslated Regions | 1 | 2012 | 164 | 0.090 |
Why?
|
| Hospitalization | 1 | 2019 | 1769 | 0.090 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2012 | 328 | 0.090 |
Why?
|
| CD59 Antigens | 1 | 2009 | 2 | 0.080 |
Why?
|
| Pituitary Diseases | 1 | 2009 | 11 | 0.080 |
Why?
|
| Complement C5a | 1 | 2009 | 24 | 0.080 |
Why?
|
| Treatment Outcome | 1 | 2025 | 12286 | 0.080 |
Why?
|
| Brain Edema | 1 | 2009 | 68 | 0.080 |
Why?
|
| Burns | 1 | 2009 | 76 | 0.080 |
Why?
|
| Encephalitis | 1 | 2009 | 109 | 0.070 |
Why?
|
| Aged, 80 and over | 1 | 2019 | 6464 | 0.070 |
Why?
|
| Child, Preschool | 3 | 2025 | 13998 | 0.060 |
Why?
|
| Sepsis | 1 | 2009 | 468 | 0.060 |
Why?
|
| Xenograft Model Antitumor Assays | 3 | 2012 | 882 | 0.060 |
Why?
|
| Brain Injuries | 1 | 2009 | 765 | 0.050 |
Why?
|
| Antineoplastic Agents | 1 | 2010 | 1652 | 0.050 |
Why?
|
| Immunoblotting | 2 | 2012 | 310 | 0.040 |
Why?
|
| Aged | 1 | 2019 | 19532 | 0.040 |
Why?
|
| Artificial Intelligence | 1 | 2024 | 240 | 0.040 |
Why?
|
| Gene Dosage | 2 | 2012 | 439 | 0.040 |
Why?
|
| In Situ Hybridization, Fluorescence | 2 | 2012 | 762 | 0.040 |
Why?
|
| Infant | 2 | 2025 | 12466 | 0.040 |
Why?
|
| Mutation | 1 | 2012 | 5818 | 0.040 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 2 | 2012 | 1015 | 0.040 |
Why?
|
| Incidence | 1 | 2025 | 3134 | 0.030 |
Why?
|
| Brain | 1 | 2009 | 2977 | 0.030 |
Why?
|
| Pediatrics | 1 | 2024 | 1157 | 0.030 |
Why?
|
| Cell Line, Tumor | 2 | 2012 | 3331 | 0.030 |
Why?
|
| Mice | 4 | 2012 | 17586 | 0.030 |
Why?
|
| Biomarkers, Tumor | 2 | 2012 | 1475 | 0.030 |
Why?
|
| Apoptosis | 2 | 2010 | 1778 | 0.030 |
Why?
|
| Animals | 5 | 2012 | 34004 | 0.030 |
Why?
|
| Amyloid Precursor Protein Secretases | 1 | 2012 | 60 | 0.020 |
Why?
|
| Class I Phosphatidylinositol 3-Kinases | 1 | 2012 | 73 | 0.020 |
Why?
|
| Immunoprecipitation | 1 | 2012 | 198 | 0.020 |
Why?
|
| src-Family Kinases | 1 | 2012 | 90 | 0.020 |
Why?
|
| Mice, Nude | 1 | 2012 | 708 | 0.020 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2012 | 256 | 0.020 |
Why?
|
| Cell Separation | 1 | 2010 | 227 | 0.020 |
Why?
|
| Signal Transduction | 2 | 2012 | 4498 | 0.020 |
Why?
|
| Receptor, Anaphylatoxin C5a | 1 | 2009 | 12 | 0.020 |
Why?
|
| Complement Membrane Attack Complex | 1 | 2009 | 7 | 0.020 |
Why?
|
| Fas Ligand Protein | 1 | 2009 | 33 | 0.020 |
Why?
|
| fas Receptor | 1 | 2009 | 41 | 0.020 |
Why?
|
| Phosphopyruvate Hydratase | 1 | 2009 | 31 | 0.020 |
Why?
|
| bcl-2-Associated X Protein | 1 | 2009 | 70 | 0.020 |
Why?
|
| Demyelinating Diseases | 1 | 2009 | 64 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2009 | 172 | 0.020 |
Why?
|
| Flow Cytometry | 1 | 2010 | 795 | 0.020 |
Why?
|
| Immunohistochemistry | 1 | 2010 | 1690 | 0.020 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2010 | 530 | 0.020 |
Why?
|
| Immunoglobulin G | 1 | 2009 | 776 | 0.020 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2009 | 1229 | 0.020 |
Why?
|
| Gene Expression Profiling | 1 | 2012 | 1699 | 0.020 |
Why?
|
| MicroRNAs | 1 | 2012 | 833 | 0.020 |
Why?
|
| Cell Proliferation | 1 | 2010 | 2283 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 2009 | 2815 | 0.010 |
Why?
|
| Rats | 1 | 2009 | 3675 | 0.010 |
Why?
|
| Mice, Knockout | 1 | 2009 | 3720 | 0.010 |
Why?
|
| Biomarkers | 1 | 2009 | 3050 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 2009 | 4394 | 0.010 |
Why?
|
| Neurons | 1 | 2009 | 1954 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2009 | 4335 | 0.010 |
Why?
|